Show Stocks and Investing Publications • Tue, October 10, 2023
Michael Ulz Maintained (ALNY) at Hold with Decreased Target to $175 on, Oct 10th, 2023
z-maintained-alny-at-hold-with-decreased-target-to-175-on-oct-10th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIMichael Ulz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $210 to $175 on, Oct 10th, 2023.
Michael has made no other calls on ALNY in the last 4 months.
There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $190 on, Thursday, September 14th, 2023
These are the ratings of the 6 analyists that currently disagree with Michael
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $200 on, Monday, October 9th, 2023
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $270 on, Friday, October 6th, 2023
- Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $208 on, Friday, September 29th, 2023
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $405 on, Monday, September 18th, 2023
- Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
- Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023